Ledger.Open graph →
SEC Form D · filed November 14, 2024

Cadrenal Therapeutics, Inc

Offering
$9.4M
Sold
$9.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PONTE VEDRA, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Robert W. Lisicki · Ponte Vedra, FLExec · DirectorSteven W. Zelenkofske · Ponte Vedra, FLDirectorJohn R. Murphy · Ponte Vedra, FLDirectorJeff W. Cole · Ponte Vedra, FLExecGlynn W. Wilson · Ponte Vedra, FLDirectorMatthew Szot · Ponte Vedra, FLExecDouglas W. Losordo · Ponte Vedra, FLExecQuang Pham · Ponte Vedra, FLExec · DirectorRobert W. Lisicki · Ponte Vedra, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗